Antihistamine Clinical Trials
3 recruitingDrug
Phase 11Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC230 enrolled59 locationsNCT05319730
Recruiting
Antihistamines, Amantadine and Evolution of COVID-19
COVID-19
Consorci Sanitari de Terrassa140,660 enrolled2 locationsNCT05504057
Recruiting
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
COVID19Influenza vaccinationARB+3 more
Consorci Sanitari de Terrassa3,000 enrolled1 locationNCT04367883